Plasma tissue inhibitor of matrix metalloproteinase-1 a predictor of long-term mortality in patients treated with cardiac resynchronization therapy. [electronic resource]
Producer: 20161213Description: 232-7 p. digitalISSN:- 1532-2092
- Aged
- Area Under Curve
- Biomarkers -- blood
- Cardiac Resynchronization Therapy -- adverse effects
- Cause of Death
- Disease-Free Survival
- Female
- Heart Failure -- blood
- Heart Transplantation
- Humans
- Kaplan-Meier Estimate
- Male
- Matrix Metalloproteinase 2 -- blood
- Middle Aged
- Multivariate Analysis
- Predictive Value of Tests
- Proportional Hazards Models
- Prospective Studies
- ROC Curve
- Risk Factors
- Time Factors
- Tissue Inhibitor of Metalloproteinase-1 -- blood
- Treatment Outcome
- Ventricular Function, Left
- Ventricular Remodeling
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.